Drugs for Vulvovaginal Candidiasis Market 2027 by Type, Applications | The Insight Partners

Drugs for Vulvovaginal Candidiasis Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Type (Cream, Pessary, Other); Applications (Hospital and Clinic, Pharmacy)

Report Code: TIPRE00009111 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Vulvovaginal candidiasis refers to vaginal and vulval symptoms caused by a yeast. It affects 75% of women on at least one occasion over a lifetime. Overgrowth of vaginal candida may result in White curd-like vaginal discharge-a burning sensation in the vagina and vulva. Drugs for vulvovaginal candidiasis helps to get rid of diseases.

MARKET DYNAMICS

The surging consumer inclination identified towards maintaining aesthetic appearance, coupled with the surging hygiene awareness, especially in developing countries, will open new doors of opportunities that may drive the growth of the global drugs for vulvovaginal candidiasis market. However, low reimbursement policies are restraining market growth. Moreover, the increase in several patients affected by candidiasis infection and high adoption due to innovative drugs is expected to benefit the growth of the market in the forecast period.

MARKET SCOPE

The "Drugs for Vulvovaginal Candidiasis Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of in drugs for vulvovaginal candidiasis market with detailed market segmentation by type, application and geography. The drugs for vulvovaginal candidiasis market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in drugs for vulvovaginal candidiasis market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The drugs for vulvovaginal candidiasis market is segmented on the basis of type, and application. Based on type the market is segmented as cream, pessary and other. On the basis of application the market is categorized as hospital & clinic and pharmacy.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in drugs for vulvovaginal candidiasis market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The drugs for vulvovaginal candidiasis market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting drugs for vulvovaginal candidiasis market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the drugs for vulvovaginal candidiasis market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in drugs for vulvovaginal candidiasis market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in drugs for vulvovaginal candidiasis market are anticipated to have lucrative growth opportunities in the future with the rising demand for in drugs for vulvovaginal candidiasis market in the global market. Below mentioned is the list of few companies engaged in the drugs for vulvovaginal candidiasis market.

The report also includes the profiles of key in drugs for vulvovaginal candidiasis market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Bayer AG
- Bristol-Myers Squibb Company
- Cisen Pharmaceuticals India Private Limited
- EFFIK LABORATORIES
- Janssen Global Services, LLC
- Johnson & Johnson Services, Inc
- Perrigo Company plc,
- Pfizer Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Drugs For Vulvovaginal Candidiasis Market - By Type
1.3.2 Drugs For Vulvovaginal Candidiasis Market - By Applications
1.3.3 Drugs For Vulvovaginal Candidiasis Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DRUGS FOR VULVOVAGINAL CANDIDIASIS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DRUGS FOR VULVOVAGINAL CANDIDIASIS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. DRUGS FOR VULVOVAGINAL CANDIDIASIS MARKET - GLOBAL MARKET ANALYSIS
6.1. DRUGS FOR VULVOVAGINAL CANDIDIASIS - GLOBAL MARKET OVERVIEW
6.2. DRUGS FOR VULVOVAGINAL CANDIDIASIS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. DRUGS FOR VULVOVAGINAL CANDIDIASIS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. CREAM
7.3.1. Overview
7.3.2. Cream Market Forecast and Analysis
7.4. PESSARY
7.4.1. Overview
7.4.2. Pessary Market Forecast and Analysis
7.5. OTHER
7.5.1. Overview
7.5.2. Other Market Forecast and Analysis
8. DRUGS FOR VULVOVAGINAL CANDIDIASIS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATIONS
8.1. OVERVIEW
8.2. APPLICATIONS MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL AND CLINIC
8.3.1. Overview
8.3.2. Hospital and Clinic Market Forecast and Analysis
8.4. PHARMACY
8.4.1. Overview
8.4.2. Pharmacy Market Forecast and Analysis
9. DRUGS FOR VULVOVAGINAL CANDIDIASIS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Drugs For Vulvovaginal Candidiasis Market Overview
9.1.2 North America Drugs For Vulvovaginal Candidiasis Market Forecasts and Analysis
9.1.3 North America Drugs For Vulvovaginal Candidiasis Market Forecasts and Analysis - By Type
9.1.4 North America Drugs For Vulvovaginal Candidiasis Market Forecasts and Analysis - By Applications
9.1.5 North America Drugs For Vulvovaginal Candidiasis Market Forecasts and Analysis - By Countries
9.1.5.1 United States Drugs For Vulvovaginal Candidiasis Market
9.1.5.1.1 United States Drugs For Vulvovaginal Candidiasis Market by Type
9.1.5.1.2 United States Drugs For Vulvovaginal Candidiasis Market by Applications
9.1.5.2 Canada Drugs For Vulvovaginal Candidiasis Market
9.1.5.2.1 Canada Drugs For Vulvovaginal Candidiasis Market by Type
9.1.5.2.2 Canada Drugs For Vulvovaginal Candidiasis Market by Applications
9.1.5.3 Mexico Drugs For Vulvovaginal Candidiasis Market
9.1.5.3.1 Mexico Drugs For Vulvovaginal Candidiasis Market by Type
9.1.5.3.2 Mexico Drugs For Vulvovaginal Candidiasis Market by Applications
9.2. EUROPE
9.2.1 Europe Drugs For Vulvovaginal Candidiasis Market Overview
9.2.2 Europe Drugs For Vulvovaginal Candidiasis Market Forecasts and Analysis
9.2.3 Europe Drugs For Vulvovaginal Candidiasis Market Forecasts and Analysis - By Type
9.2.4 Europe Drugs For Vulvovaginal Candidiasis Market Forecasts and Analysis - By Applications
9.2.5 Europe Drugs For Vulvovaginal Candidiasis Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Drugs For Vulvovaginal Candidiasis Market
9.2.5.1.1 Germany Drugs For Vulvovaginal Candidiasis Market by Type
9.2.5.1.2 Germany Drugs For Vulvovaginal Candidiasis Market by Applications
9.2.5.2 France Drugs For Vulvovaginal Candidiasis Market
9.2.5.2.1 France Drugs For Vulvovaginal Candidiasis Market by Type
9.2.5.2.2 France Drugs For Vulvovaginal Candidiasis Market by Applications
9.2.5.3 Italy Drugs For Vulvovaginal Candidiasis Market
9.2.5.3.1 Italy Drugs For Vulvovaginal Candidiasis Market by Type
9.2.5.3.2 Italy Drugs For Vulvovaginal Candidiasis Market by Applications
9.2.5.4 Spain Drugs For Vulvovaginal Candidiasis Market
9.2.5.4.1 Spain Drugs For Vulvovaginal Candidiasis Market by Type
9.2.5.4.2 Spain Drugs For Vulvovaginal Candidiasis Market by Applications
9.2.5.5 United Kingdom Drugs For Vulvovaginal Candidiasis Market
9.2.5.5.1 United Kingdom Drugs For Vulvovaginal Candidiasis Market by Type
9.2.5.5.2 United Kingdom Drugs For Vulvovaginal Candidiasis Market by Applications
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Drugs For Vulvovaginal Candidiasis Market Overview
9.3.2 Asia-Pacific Drugs For Vulvovaginal Candidiasis Market Forecasts and Analysis
9.3.3 Asia-Pacific Drugs For Vulvovaginal Candidiasis Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Drugs For Vulvovaginal Candidiasis Market Forecasts and Analysis - By Applications
9.3.5 Asia-Pacific Drugs For Vulvovaginal Candidiasis Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Drugs For Vulvovaginal Candidiasis Market
9.3.5.1.1 Australia Drugs For Vulvovaginal Candidiasis Market by Type
9.3.5.1.2 Australia Drugs For Vulvovaginal Candidiasis Market by Applications
9.3.5.2 China Drugs For Vulvovaginal Candidiasis Market
9.3.5.2.1 China Drugs For Vulvovaginal Candidiasis Market by Type
9.3.5.2.2 China Drugs For Vulvovaginal Candidiasis Market by Applications
9.3.5.3 India Drugs For Vulvovaginal Candidiasis Market
9.3.5.3.1 India Drugs For Vulvovaginal Candidiasis Market by Type
9.3.5.3.2 India Drugs For Vulvovaginal Candidiasis Market by Applications
9.3.5.4 Japan Drugs For Vulvovaginal Candidiasis Market
9.3.5.4.1 Japan Drugs For Vulvovaginal Candidiasis Market by Type
9.3.5.4.2 Japan Drugs For Vulvovaginal Candidiasis Market by Applications
9.3.5.5 South Korea Drugs For Vulvovaginal Candidiasis Market
9.3.5.5.1 South Korea Drugs For Vulvovaginal Candidiasis Market by Type
9.3.5.5.2 South Korea Drugs For Vulvovaginal Candidiasis Market by Applications
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Drugs For Vulvovaginal Candidiasis Market Overview
9.4.2 Middle East and Africa Drugs For Vulvovaginal Candidiasis Market Forecasts and Analysis
9.4.3 Middle East and Africa Drugs For Vulvovaginal Candidiasis Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Drugs For Vulvovaginal Candidiasis Market Forecasts and Analysis - By Applications
9.4.5 Middle East and Africa Drugs For Vulvovaginal Candidiasis Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Drugs For Vulvovaginal Candidiasis Market
9.4.5.1.1 South Africa Drugs For Vulvovaginal Candidiasis Market by Type
9.4.5.1.2 South Africa Drugs For Vulvovaginal Candidiasis Market by Applications
9.4.5.2 Saudi Arabia Drugs For Vulvovaginal Candidiasis Market
9.4.5.2.1 Saudi Arabia Drugs For Vulvovaginal Candidiasis Market by Type
9.4.5.2.2 Saudi Arabia Drugs For Vulvovaginal Candidiasis Market by Applications
9.4.5.3 U.A.E Drugs For Vulvovaginal Candidiasis Market
9.4.5.3.1 U.A.E Drugs For Vulvovaginal Candidiasis Market by Type
9.4.5.3.2 U.A.E Drugs For Vulvovaginal Candidiasis Market by Applications
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Drugs For Vulvovaginal Candidiasis Market Overview
9.5.2 South and Central America Drugs For Vulvovaginal Candidiasis Market Forecasts and Analysis
9.5.3 South and Central America Drugs For Vulvovaginal Candidiasis Market Forecasts and Analysis - By Type
9.5.4 South and Central America Drugs For Vulvovaginal Candidiasis Market Forecasts and Analysis - By Applications
9.5.5 South and Central America Drugs For Vulvovaginal Candidiasis Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Drugs For Vulvovaginal Candidiasis Market
9.5.5.1.1 Brazil Drugs For Vulvovaginal Candidiasis Market by Type
9.5.5.1.2 Brazil Drugs For Vulvovaginal Candidiasis Market by Applications
9.5.5.2 Argentina Drugs For Vulvovaginal Candidiasis Market
9.5.5.2.1 Argentina Drugs For Vulvovaginal Candidiasis Market by Type
9.5.5.2.2 Argentina Drugs For Vulvovaginal Candidiasis Market by Applications
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. DRUGS FOR VULVOVAGINAL CANDIDIASIS MARKET, KEY COMPANY PROFILES
11.1. BAYER AG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BRISTOL-MYERS SQUIBB COMPANY
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CISEN PHARMACEUTICALS INDIA PRIVATE LIMITED
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. EFFIK LABORATORIES
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. JANSSEN GLOBAL SERVICES, LLC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. JOHNSON AND JOHNSON SERVICES, INC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PERRIGO COMPANY PLC,
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PFIZER INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SANOFI
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Bayer AG
2. Bristol-Myers Squibb Company
3. Cisen Pharmaceuticals India Private Limited
4. EFFIK LABORATORIES
5. Janssen Global Services, LLC
6. Johnson & Johnson Services, Inc
7. Perrigo Company plc,
8. Pfizer Inc.
9. Sanofi
10. Teva Pharmaceutical Industries Ltd.
TIPRE00009111
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking